This page contains affiliate links. We may earn a commission if you sign up through them, at no cost to you. All recommendations are independent.

Semaglutide vs Tirzepatide in Oral Form: The Cross-Molecule Oral Comparison

Both semaglutide and tirzepatide are available in compounded oral formulations. Choosing between them involves the same molecule considerations that apply to injectable, plus oral-specific factors. Here's the direct comparison.

The Underlying Molecule Difference

Semaglutide is a GLP-1 receptor agonist. Tirzepatide is a dual GLP-1 and GIP receptor agonist. The dual receptor engagement in tirzepatide typically produces greater weight loss magnitude at maintenance doses — this holds across oral and injectable forms, though absolute magnitudes are smaller for oral than injectable of either molecule.

The Regulatory Environment

Compounded oral semaglutide competes with brand-name Wegovy pill and Rybelsus in the same molecule and route category. This creates competitive pricing pressure and some regulatory ambiguity. Compounded oral tirzepatide has no brand-name equivalent — Lilly hasn't developed an oral tirzepatide product commercially — which gives compounded oral tirzepatide stronger regulatory footing.

MadeMed

Compounded oral tirzepatide ~$167–$229/mo

Independent compounder — oral tirzepatide specialty.

  • Compounded oral tirzepatide
  • $167–$229 range by dose tier
  • Direct pharmacy fulfillment
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

Pricing Comparison

Compounded oral semaglutide typically runs $99-$179/month across credible providers. Compounded oral tirzepatide typically runs $167-$229/month. The oral tirzepatide premium reflects both higher milligram content (needed for equivalent effect at the molecule level) and the more stable regulatory positioning.

Telos Rx

$365 CPA — compounded pathway

Compounded GLP-1 via direct pharmacy program.

  • Compounded GLP-1 focus
  • Direct-link intake format
  • Verify pricing at intake
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

Efficacy Expectations

Oral tirzepatide is generally expected to produce greater weight loss than oral semaglutide, matching the injectable molecule comparison. Individual variability is substantial — some patients respond better to one molecule than the other regardless of which is "typically" more potent.

Both molecules require several months of titration to reach maintenance doses and see full effect. Impatience with early response can lead to premature discontinuation.

MadeMed

Compounded oral tirzepatide ~$167–$229/mo

Independent compounder — oral tirzepatide specialty.

  • Compounded oral tirzepatide
  • $167–$229 range by dose tier
  • Direct pharmacy fulfillment
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

How to Choose

Choose oral semaglutide if: cost is a primary consideration, target weight loss is moderate, or you want the same molecule family as brand-name Wegovy pill. Choose oral tirzepatide if: maximum weight loss is the priority, budget accommodates the higher tier, you've tried semaglutide without adequate response, or you want the more regulatorily stable compounded option.

Telos Rx

$365 CPA — compounded pathway

Compounded GLP-1 via direct pharmacy program.

  • Compounded GLP-1 focus
  • Direct-link intake format
  • Verify pricing at intake
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

MadeMed

Compounded oral tirzepatide ~$167–$229/mo

Independent compounder — oral tirzepatide specialty.

  • Compounded oral tirzepatide
  • $167–$229 range by dose tier
  • Direct pharmacy fulfillment
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

Where to Start

MadeMed

Compounded oral tirzepatide ~$167–$229/mo

Independent compounder — oral tirzepatide specialty.

  • Compounded oral tirzepatide
  • $167–$229 range by dose tier
  • Direct pharmacy fulfillment
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

Telos Rx

$365 CPA — compounded pathway

Compounded GLP-1 via direct pharmacy program.

  • Compounded GLP-1 focus
  • Direct-link intake format
  • Verify pricing at intake
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing